Skip to content

Fatigue Severity Scale

Three-Year Follow-Up Study in Patients with Guillain-Barré Syndrome.

CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.

Hyponatremia is a predictor for poor outcome in Guillain-Barré syndrome.

Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.

Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Different IVIG Glycoforms Affect In Vitro Inhibition of Anti-Ganglioside Antibody-Mediated Complement Deposition.Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDPIntravenous immunoglobulin for Guillain-Barré syndrome.